GlassScriptPhysician profile
Eric Paul Rose
NPI 1083123012
$1,517.71
in general payments reported to CMS, 2019-2025
13 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.94 · 2024: $391 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090 · Travel and Lodging: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.48 |
| Travel and Lodging | $397.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $692.71 | 2024-2025 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $298.23 | 2024 | Evoke |
| Medtronic, INC. | $273.06 | 2025 | Intellis Adaptivestim |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.64 | 2025 | Caplyta |
| Nevro Corp. | $31.27 | 2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $29.94 | 2022 | |
| Corcept Therapeutics | $29.34 | 2025 | Korlym |
| Lilly USA, LLC | $29.07 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $28.55 | 2024-2025 | Wegovy |
| Vertex Pharmaceuticals Incorporated | $21.13 | 2025 | |
| Antares Pharma, INC. | $17.47 | 2024 | Xyosted |
| Abbvie INC. | $17.15 | 2025 | |
| Exact Sciences Corporation | $17.15 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.